Article info
PDFInflammatory bowel disease
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
- Correspondence to:
Dr T Hibi
Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan; thibi{at}sc.itc.keio.ac.jp
Citation
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
Publication history
- Accepted January 30, 2006
- Revised January 27, 2006
- First published February 16, 2006.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Gut